{"id":3212,"date":"2026-06-10T06:00:52","date_gmt":"2026-06-10T11:00:52","guid":{"rendered":"https:\/\/www.worldcare.com\/?p=3212"},"modified":"2026-06-10T06:49:13","modified_gmt":"2026-06-10T11:49:13","slug":"co-prelom-v-oblasti-rakoviny-pankreasu-hovori-poistovniam-o-odbornych-lekarskych-nazoroch","status":"publish","type":"post","link":"https:\/\/www.worldcare.com\/sk\/what-a-pancreatic-cancer-breakthrough-tells-insurers-about-expert-medical-opinions\/","title":{"rendered":"\u010co prelom v rakovine pankreasu hovor\u00ed pois\u0165ovniam o odborn\u00fdch lek\u00e1rskych n\u00e1zoroch"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"3212\" class=\"elementor elementor-3212\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5b2feeaa e-flex e-con-boxed e-con e-parent\" data-id=\"5b2feeaa\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-baac94d elementor-widget elementor-widget-text-editor\" data-id=\"baac94d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Liek, ktor\u00fd vedci naz\u00fdvaj\u00fa \u201cekvivalentom prekonania m\u00edle za \u0161tyri min\u00faty v boji proti rakovine\u201d, sa bl\u00ed\u017ei ku schv\u00e1leniu regula\u010dn\u00fdmi org\u00e1nmi. Daraxonrasib cieli na prote\u00edn, ktor\u00fd je zodpovedn\u00fd za vznik takmer v\u0161etk\u00fdch n\u00e1dorov pankreasu \u2013 ako aj mnoh\u00fdch druhov rakoviny p\u013e\u00fac a hrub\u00e9ho \u010dreva \u2013 a v <a href=\"https:\/\/ir.revmed.com\/news-releases\/news-release-details\/daraxonrasib-demonstrates-unprecedented-overall-survival-benefit\/\" target=\"_blank\" rel=\"noreferrer noopener\">k\u013e\u00fa\u010dov\u00e1 \u0161t\u00fadia v neskor\u0161om \u0161t\u00e1diu,<\/a> takmer zdvojn\u00e1sobil medi\u00e1n pre\u017eitia u pacientov s metastatick\u00fdm karcin\u00f3mom pankreasu zo 6,7 mesiaca na 13,2 mesiaca.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p>T\u00e1to inov\u00e1cia je pozoruhodn\u00e1 svoj\u00edm potenci\u00e1lom prepracova\u0165 lie\u010debn\u00e9 postupy a porovn\u00e1va sa s prelomov\u00fdm vplyvom imunoterapie spred 15 rokov.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p>Je tie\u017e pozoruhodn\u00e9, kam patr\u00ed v \u0161ir\u0161om vzorci: Zatia\u013e \u010do prelomov\u00e9 objavy ako Daraxonrasib prich\u00e1dzaj\u00fa sporadicky, medic\u00ednske poznatky celkovo napreduj\u00fa tempom, ktor\u00e9 \u017eiadny jednotliv\u00fd lek\u00e1r, syst\u00e9m zdravotnej starostlivosti ani krajina nedok\u00e1\u017eu \u00faplne absorbova\u0165 samostatne \u2013 a ke\u010f\u017ee glob\u00e1lne, multidisciplin\u00e1rne lek\u00e1rske druh\u00e9 n\u00e1zory s\u00fa dostupnej\u0161ie ako kedyko\u013evek predt\u00fdm prostredn\u00edctvom zdravotn\u00fdch pl\u00e1nov, poistenia kritick\u00fdch chor\u00f4b a dokonca aj slu\u017eieb, ako s\u00fa kreditn\u00e9 karty alebo v\u00fdhody hotelov\u00e9ho pridru\u017eenia, nemusia to robi\u0165. \u00a0<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:heading --><\/p>\n<h2 class=\"wp-block-heading\"><strong>Tempo inov\u00e1ci\u00ed v onkol\u00f3gii je bud\u00ed\u010dkom pre zdravotn\u00e9 pois\u0165ovne<\/strong><\/h2>\n<p><!-- \/wp:heading --><!-- wp:paragraph --><\/p>\n<p>Pokroky v oblasti liekov a medic\u00ednskych technol\u00f3gi\u00ed poskytuj\u00fa hmatate\u013en\u00e9 ukazovatele ohromuj\u00faceho tempa medic\u00ednskych inov\u00e1ci\u00ed. Zamyslite sa nad t\u00fdm, \u010do sa stalo len za posledn\u00e9 mesiace:<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:list --><\/p>\n<ul class=\"wp-block-list\">\n<li style=\"list-style-type: none;\">\n<ul class=\"wp-block-list\"><!-- wp:list-item --><\/ul>\n<\/li>\n<\/ul>\n<ul class=\"wp-block-list\">\n<li style=\"list-style-type: none;\">\n<ul class=\"wp-block-list\">\n<li>Od m\u00e1ja 2026 <a href=\"https:\/\/www.ema.europa.eu\/en\/news\/meeting-highlights-committee-medicinal-products-human-use-chmp-18-21-may-2026\" target=\"_blank\" rel=\"noopener\">Eur\u00f3pska agent\u00fara pre lieky<\/a>\u00a0vydala 36 pozit\u00edvnych stanov\u00edsk k nov\u00fdm liekom a 59 \u010fal\u0161\u00edch stanov\u00edsk, ktor\u00fdmi sa roz\u0161iruje schv\u00e1len\u00e9 pou\u017eitie existuj\u00facich lie\u010debn\u00fdch postupov.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><!-- \/wp:list-item --><!-- wp:list-item --><\/p>\n<ul class=\"wp-block-list\">\n<li style=\"list-style-type: none;\">\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.canada.ca\/en\/health-canada\/news\/2026\/03\/new-task-force-to-enhance-canadas-competitiveness-and-improve-access-to-innovative-medicines.html\" target=\"_blank\" rel=\"noreferrer noopener\">Zdravotn\u00edctvo Kanady <\/a>V obdob\u00ed od apr\u00edla 2025 do febru\u00e1ra 2026 schv\u00e1lila spolo\u010dnos\u0165 56 nov\u00fdch farmaceutick\u00fdch liekov, 23 nov\u00fdch biologick\u00fdch liekov, 134 generick\u00fdch farmaceutick\u00fdch liekov a 12 biosimil\u00e1rnych liekov. Z nich 43 obsahuje lie\u010div\u00e9 zlo\u017eky, ktor\u00e9 predt\u00fdm neboli schv\u00e1len\u00e9 na predaj v Kanade.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><!-- \/wp:list-item --><!-- wp:list-item --><\/p>\n<ul class=\"wp-block-list\">\n<li style=\"list-style-type: none;\">\n<ul class=\"wp-block-list\">\n<li>Od 1. j\u00fana 2026 <a href=\"https:\/\/www.fda.gov\/drugs\/novel-drug-approvals-fda\/novel-drug-approvals-2026\" target=\"_blank\" rel=\"noreferrer noopener\">Americk\u00fd \u00farad pre kontrolu potrav\u00edn a lie\u010div<\/a> schv\u00e1lila 20 \u00faplne nov\u00fdch liekov, nepo\u010d\u00edtaj\u00fac nov\u00e9 indik\u00e1cie.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><!-- \/wp:list-item --><\/p>\n<p><!-- \/wp:list --><!-- wp:paragraph --><\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p>Najm\u00e4 tempo inov\u00e1ci\u00ed v onkol\u00f3gii sa neust\u00e1le zr\u00fdch\u013euje. Za posledn\u00e9 desa\u0165ro\u010die bolo schv\u00e1len\u00fdch 115 nov\u00fdch lie\u010debn\u00fdch postupov pre 10 najroz\u0161\u00edrenej\u0161\u00edch typov rakoviny \u2013 oproti 28 schv\u00e1leniam v predch\u00e1dzaj\u00facom desa\u0165ro\u010d\u00ed, uv\u00e1dza... <a href=\"https:\/\/www.airfinity.com\/articles\/300-rise-in-approved-new-cancer-treatments-in-the-last-two-decades-with-us\" target=\"_blank\" rel=\"noreferrer noopener\">Anal\u00fdza vzdu\u0161nej nekone\u010dnosti<\/a> ktor\u00fd tie\u017e poznamen\u00e1va, \u017ee v\u00fdznamn\u00fa \u010das\u0165 tvoria kombinovan\u00e9 lie\u010dby pou\u017e\u00edvan\u00e9 v cielen\u00fdch terapi\u00e1ch.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:heading --><\/p>\n<h2 class=\"wp-block-heading\"><strong>Multidisciplin\u00e1rne lek\u00e1rske druh\u00e9 n\u00e1zory pom\u00e1haj\u00fa pois\u0165ovniam preklen\u00fa\u0165 medzeru vo vedomostiach<\/strong><\/h2>\n<p><!-- \/wp:heading --><!-- wp:paragraph --><\/p>\n<p>Medic\u00ednske znalosti sa teraz odhaduj\u00fa na <a href=\"https:\/\/connection.asco.org\/do\/staying-current-todays-era-rapidly-evolving-medical-advances#:~:text=1,decade%20from%202010%20to%202020.%E2%80%9D\" target=\"_blank\" rel=\"noreferrer noopener\">zdvojn\u00e1sobuje sa ka\u017ed\u00fdch 73 dn\u00ed<\/a>, pod\u013ea Americkej spolo\u010dnosti pre klinick\u00fa onkol\u00f3giu. \u017diaden lek\u00e1r s t\u00fdm nedok\u00e1\u017ee dr\u017ea\u0165 krok. Ako povedal chirurg a autor Atul Gawande <a href=\"https:\/\/www.newyorker.com\/news\/news-desk\/cowboys-and-pit-crews\" target=\"_blank\" rel=\"noreferrer noopener\">argumentoval<\/a>, medic\u00edna sa stala pr\u00edli\u0161 komplexnou pre model s\u00f3lov\u00e9ho experta. Modern\u00fd \u0161tandard vy\u017eaduje multidisciplin\u00e1rnu, t\u00edmov\u00fa \u0161pecializovan\u00fa starostlivos\u0165.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p>Toto je miesto, kde <a href=\"http:\/\/www.worldcare.com\/sk\/\" target=\"_blank\" rel=\"noreferrer noopener\" data-type=\"link\" data-id=\"www.worldcare.com\">glob\u00e1lne lek\u00e1rske druh\u00e9 n\u00e1zory <\/a>sta\u0165 sa kritick\u00fdmi. Ke\u010f pacient v Po\u013esku, Kanade alebo Saudskej Ar\u00e1bii dostane v\u00e1\u017enu diagn\u00f3zu, jeho v\u00fdsledok z\u00e1vis\u00ed od toho, \u010di m\u00e1 jeho o\u0161etruj\u00faci t\u00edm pr\u00edstup k \u0161pecialistom, ktor\u00ed poznaj\u00fa najnov\u0161ie d\u00f4kazy a vedia ich aplikova\u0165 na jeho konkr\u00e9tny pr\u00edpad.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p>Prelom, ktor\u00fd sa dnes bl\u00ed\u017ei ku schv\u00e1leniu FDA alebo EMA, by sa mohol sta\u0165 \u0161tandardom starostlivosti do roka. Pre skupinov\u00e9 zdravotn\u00e9 pl\u00e1ny, poistky kritick\u00fdch chor\u00f4b a poradcov pre osoby so z\u00e1va\u017en\u00fdmi ochoreniami, ktor\u00ed sl\u00fa\u017eia \u010dlenom v Severnej Amerike, Eur\u00f3pe, Afrike a Perzskom z\u00e1live, u\u017e medzin\u00e1rodn\u00e9 odborn\u00e9 lek\u00e1rske stanovisko nie je doplnkovou ponukou \u2013 je to zv\u00fd\u0161enie benefitov, ktor\u00e9 priamo ovplyv\u0148uje kvalitu starostlivosti, ktor\u00fa \u010dlenovia dost\u00e1vaj\u00fa, a presnos\u0165 n\u00e1sledn\u00fdch n\u00e1rokov.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p>Pon\u00fakanie pr\u00edstupu k druh\u00fdm n\u00e1zorom multidisciplin\u00e1rneho t\u00edmu na z\u00e1va\u017en\u00e9 a zlo\u017eit\u00e9 diagn\u00f3zy je jednou z najjasnej\u0161\u00edch foriem inov\u00e1ci\u00ed v oblasti skupinov\u00fdch benefitov, ktor\u00e9 s\u00fa dnes k dispoz\u00edcii pois\u0165ovniam. Na trhu, kde sa medic\u00ednske poznatky hromadia r\u00fdchlej\u0161ie, ako to dok\u00e1\u017ee ktor\u00fdko\u013evek lek\u00e1r sledova\u0165, je to tie\u017e jedna z najodolnej\u0161\u00edch mo\u017enost\u00ed.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p><!-- \/wp:paragraph --><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>A drug that scientists are calling \u201ccancer&#8217;s equivalent of breaking the four-minute mile\u201d is nearing regulatory approval. Daraxonrasib targets a protein that drives nearly all pancreatic tumors \u2014 as well as many lung and colon cancers \u2014 and in a late-stage pivotal trial, it nearly doubled median survival in patients with metastatic pancreatic cancer from [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":3256,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[158,35,16],"tags":[],"class_list":["post-3212","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-innovation","category-cancer","category-medical-second-opinion"],"_links":{"self":[{"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/posts\/3212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/comments?post=3212"}],"version-history":[{"count":0,"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/posts\/3212\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/media\/3256"}],"wp:attachment":[{"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/media?parent=3212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/categories?post=3212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/tags?post=3212"}],"curies":[{"name":"pracovn\u00fd list","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}